Companies: 10,795·Total market cap: $144.5T

Immutep Limited

Immutep Limited

IMMPNASDAQHealthcare● Active

$0.37

$-0.01(-2.04%)

Market Cap$54365531

P/E Ratio—

52W High$3.53

52W Low$0.29

Avg Volume14.3M

Open$0.38

Beta2.24

Net Income Financials Revenue

Immutep Limited (IMMP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IMMP · net income · updated Jun 9, 2026

Core profitability metrics

IMMP · net income · margin · TTM · CAGR

Net income was −$61.4M for FY2025 (fiscal year ending 2025-06-30), down 43.8% year-over-year. Net profit margin was -1218.0%.

FY2025 Net Income−$61.4M▼ -43.8% YoY

Trailing 12M (TTM)−$127.8Mtrailing 4 quarters sum

Net Profit Margin< −999%−$61.4M ÷ $5.0M

YoY Change-43.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · IMMP net income history · IMMP profit margin

Annual net income data

IMMP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$61.4M▼ 43.8%-1218.0%$5.0M

FY2024Loss−$42.7M▼ 7.1%-1111.9%$3.8M

FY2023Loss−$39.9M▼ 23.9%-1138.0%$3.5M

FY2022Loss−$32.2M▼ 7.7%-18906.5%$170,369

FY2021Loss−$29.9M▼ 122.0%-774.1%$3.9M

Net income vs peers (Healthcare)

IMMP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Immutep LimitedYOU

IMMP

−$61.4M-43.8%-1218.0%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Immutep Limited (IMMP) reported net income of −$61.4M for FY2025 (fiscal year ending 2025-06-30), down 43.8% year-over-year. The net profit margin was -1218.0% — meaning the company kept $-12.18 of every dollar of revenue as profit.

Immutep Limited has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Immutep Limited's net profit margin was -1218.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Immutep Limited net worth" — the company's market capitalization is a separate figure from IMMP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IMMP net income · 4 questions

Immutep Limited is not currently profitable on an annual basis. The company reported a net loss of $61.4M for FY2025.

is IMMP profitabledoes IMMP make a profitIMMP profitabilityIMMP profitable company

▸ Source: FMP /income-statement · GAAP · Immutep Limited · Immutep Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026